BRCA1-Associated Protein-1
Showing 26 - 50 of >10,000
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors
Recruiting
- Breast Cancer
- +3 more
-
Stanford, CaliforniaStanford University School of Medicine
Sep 2, 2021
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Mar 28, 2023
Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)
Not yet recruiting
- Prostate Cancer
- +4 more
- Olaparib
- LHRH agonist
- (no location specified)
Aug 10, 2022
Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2
Recruiting
- Hereditary Breast and Ovarian Cancer
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Jun 3, 2022
InheriteD brEast caNcer iTalian regIsTrY A
Recruiting
- Breast Cancer
-
Aviano, Pordenone, Italy
- +11 more
Apr 26, 2023
Protein-energy; Imbalance, Recovery, Body Weight Trial in Cambridge (High protein supplement, Moderate protein supplement,
Completed
- Protein-energy; Imbalance
- +2 more
- High protein supplement
- +3 more
-
Cambridge, Cambridgeshire, United KingdomAnglia Ruskin University
Aug 11, 2023
Hereditary Breast and Ovarian Cancer Trial in Cologne, Kiel, Munich (Structured exercise training plus mediterranean diet)
Active, not recruiting
- Hereditary Breast and Ovarian Cancer
- Structured exercise training plus mediterranean diet
-
Cologne, Germany
- +2 more
Oct 25, 2022
Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)
Not yet recruiting
- Recurrent Metastatic Melanoma
- +3 more
-
Boston, Massachusetts
- +1 more
Jul 29, 2022
Protein-energy; Imbalance, Muscle Soreness Trial in Cambridge (High protein intake, Moderate protein intake, Carbohydrate
Completed
- Protein-energy; Imbalance
- Muscle Soreness
- High protein intake
- +3 more
-
Cambridge, Cambridgeshire, United KingdomAnglia Ruskin University
Aug 11, 2023
Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)
Active, not recruiting
- Advanced Breast Cancer
- +2 more
- Talazoparib Tosylate
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Nov 16, 2022
TNBC - Triple-Negative Breast Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (olaparib, Durvalumab)
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- +2 more
- (no location specified)
Jan 12, 2022
Type 1 Diabetes Trial in Rochester (procedure, other, dietary supplement)
Not yet recruiting
- Type 1 Diabetes
- Muscle Biopsy
- +2 more
-
Rochester, MinnesotaMayo Clinic
Aug 2, 2023
Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection, Placebo)
Not yet recruiting
- Alpha1-Antitrypsin Deficiency
- Fazirsiran Injection
- Placebo
- (no location specified)
Feb 2, 2023
Amino Acid Change, Gastrointestinal Dysfunction Trial in Cambridge (Dairy based protein, Mixed protein, Plant-based protein 1)
Recruiting
- Amino Acid Change
- Gastrointestinal Dysfunction
- Dairy based protein
- +3 more
-
Cambridge, Cambridgeshire, United KingdomAnglia Ruskin University
Jan 30, 2023
Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Pamiparib)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Apr 7, 2022
Protein Metabolism Disorder Trial in Maastricht (20g whey protein drink ingestion, 20g native canola protein drink ingestion,
Recruiting
- Protein Metabolism Disorder
- 20g whey protein drink ingestion
- +3 more
-
Maastricht, Limburg, NetherlandsMaastricht University Medical Centre+
Sep 21, 2023
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Healthy Trial (763SIP8/MPLA-5 vaccine)
Not yet recruiting
- Healthy
- 763SIP8/MPLA-5 vaccine
- (no location specified)
Mar 15, 2023
Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 Trial in Stockholm (Mifepristone)
Completed
- Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2
-
Stockholm, SwedenDepartment of Woman and Child Health Karolinska University Hospi
Jan 15, 2022
Genes Contributing to Hereditary Ovarian Cancer in Women and
Completed
- Ovarian Cancer
-
Seattle, WashingtonUniversity of Washington
Feb 2, 2022
Monocyte Chemoattractant Protein-1 in Psoriatic Arthritis
Not yet recruiting
- Psoriatic Arthritis
- (no location specified)
Nov 25, 2022
BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)
Completed
- BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
- Doxorubicin
- +3 more
-
Barretos, SP, BrazilBarretos Cancer Hospital
Dec 25, 2022
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Cancer Trial in Netherlands (Salpingectomy with delayed oophorectomy,
Active, not recruiting
- BRCA1 Gene Mutation
- +2 more
- Salpingectomy with delayed oophorectomy
- Risk-reducing salpingo-oophorectomy
-
Maastricht, Limburg, Netherlands
- +12 more
May 17, 2022